The pharmaceutical packaging industry demands ultra-high cleanliness, sterility, and chemical stability, as packaging purity directly determines drug safety and shelf stability. Traditional solvent-based polyurethane adhesives used in medical plastic packaging often suffer from solvent residues, volatile organic compound (VOC) emissions, and impurity precipitation, which fail to meet strict pharmaceutical production standards. To address these critical pain points, high-cleanliness solvent-free polyurethane (SFPU) has emerged as a standardized, reliable application solution, becoming a core material upgrade for high-end pharmaceutical plastic composite packaging.
Unlike conventional adhesive products, pharmaceutical-grade SFPU adopts a 100% solid-content, solvent-free formula with zero organic solvent addition throughout production and lamination processes. This fundamental design completely eliminates residual solvent contamination, the biggest hidden hazard in medical packaging. Traditional solvent-based adhesives require lengthy drying procedures, yet incomplete volatilization easily leaves micro-residues that may migrate into drugs, triggering quality risks such as ingredient deterioration and contamination. In contrast, SFPU cures through pure chemical cross-linking reactions between polyol and isocyanate components, delivering pure, impurity-free bonding layers that fully comply with pharmaceutical cleanliness requirements.
The high-cleanliness advantages of SFPU perfectly match the stringent production environment of pharmaceutical packaging. It adapts to Class 100,000 and Class 10,000 sterile purification workshops, producing no VOC volatilization, dust pollution or harmful precipitates during processing. The optimized molecular structure prevents extractables and leachables, ensuring no chemical interaction with tablets, capsules, injections and biological drugs. Rigorous testing verifies that SFPU packaging materials maintain stable purity after gamma ray sterilization and high-temperature disinfection, with no odor transfer or substance precipitation, meeting FDA, EMA and USP pharmaceutical packaging standards.
In practical medical packaging applications, SFPU demonstrates outstanding comprehensive performance while maintaining high cleanliness. It achieves uniform lamination and firm bonding on common medical substrates including PET, PE, PP and medical aluminum-plastic films, with no bubbling, delamination or edge warping during long-term storage and extreme temperature changes. Its excellent biocompatibility and low impurity characteristics make it suitable for sterile drug packaging, medical device blister packaging, and biological reagent packaging, effectively protecting the sterility and efficacy of pharmaceutical products.
Furthermore, the high-cleanliness SFPU solution optimizes pharmaceutical packaging production workflows. It omits complex drying and exhaust systems, reducing secondary pollution risks in the production process while cutting energy consumption. The stable curing performance lowers defective rates caused by impurity contamination, helping pharmaceutical enterprises achieve standardized, efficient and green production.
As global pharmaceutical supervision becomes increasingly rigorous, high-purity and sterile packaging has become an essential guarantee for drug quality. High-cleanliness solvent-free polyurethane solves the long-standing cleanliness bottleneck of traditional medical packaging adhesives. With its zero-residue safety, ultra-high purity and stable sterility resistance, it has become the preferred high-end solution for pharmaceutical plastic packaging, leading the upgrading and high-quality development of the medical packaging material industry.
English
España
русский
Deutsch
No.188, Liangshan Road, Linghu Town, Nanxun District, Huzhou City, Zhejiang Province, China
+86 (572)
2903236
+86 (572)
2905222
+86 15088303595
+86 15088303595
